Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
27 June 2014Website:
http://heliusmedical.comNext earnings report:
28 March 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 4 min agoDividend
Analysts recommendations
Institutional Ownership
HSDT Latest News
NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today provided updates on its efforts to achieve fair market access for its Portable Neuromodulation Stimulator (PoNS) device and announced plans to host a business update call today at 9:00am ET.
NEWTOWN, Pa., Oct. 18, 2024 – PRISM MediaWire – Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it plans to participate in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York.
NEWTOWN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended June 30, 2024.
NEWTOWN, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its second quarter 2024 financial results on Monday, August 12, 2024, after the market closes.
-- Inclusion of the top neurorehabilitation centers REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions completes site participation enrollment for the U.S. registrational program in stroke -- -- In Canada, an additional study on the use of Portable Neuromodulation Stimulator (PoNS®) Therapy to treat stroke has started to support Canadian reimbursement and U.S. approval for stroke --
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q1 2024 Results Conference Call on May 13, 2024 at 4:30 PM ET. Company Participants include Michelle Bilski from Investor Relations-In-Site Communications, Dane Andreeff - President and CEO, and Jeff Mathiesen - CFO. Conference Call Participants include Nicholas Sherwood from Maxim Group. Operator welcomes everyone to the Helius Medical Technologies First Quarter 2024 Earnings Conference Call.
Helius Medical Technology (NASDAQ: HSDT) shares are surging on Friday with high trading volume, as over 3.5 million shares of HSDT stock have been traded so far.
Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript
NEWTOWN, Pa., March 15, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its fourth quarter and full year 2023 financial results on Thursday, March 28, 2024, after the market closes.
What type of business is Helius Medical Technologies?
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
What sector is Helius Medical Technologies in?
Helius Medical Technologies is in the Healthcare sector
What industry is Helius Medical Technologies in?
Helius Medical Technologies is in the Medical Devices industry
What country is Helius Medical Technologies from?
Helius Medical Technologies is headquartered in United States
When did Helius Medical Technologies go public?
Helius Medical Technologies initial public offering (IPO) was on 27 June 2014
What is Helius Medical Technologies website?
https://heliusmedical.com
Is Helius Medical Technologies in the S&P 500?
No, Helius Medical Technologies is not included in the S&P 500 index
Is Helius Medical Technologies in the NASDAQ 100?
No, Helius Medical Technologies is not included in the NASDAQ 100 index
Is Helius Medical Technologies in the Dow Jones?
No, Helius Medical Technologies is not included in the Dow Jones index
When was Helius Medical Technologies the previous earnings report?
No data
When does Helius Medical Technologies earnings report?
The next expected earnings date for Helius Medical Technologies is 28 March 2025